Dernières nouvelles
Information non disponible
Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed)
Article de revuePediatr Hematol Oncol, 40 (7), 2023.
Signaler des ajouts ou des modifications